Neuropharmacological mechanisms of nerve agent-induced seizure and neuropathology

Neuroscience and Biobehavioral Reviews

Volumn 21, Issue 5, 1997, Pages 559-579

  McDonough Jr , John H ^a   Shih, Tsung Ming ^a  

^a US Army Med Res Inst Chem   (United States)

Author keywords

Anticholinergic drugs; Anticonvul sants; Benzodiazepines; Cholinergic; Excitatory amino acid antagonists; Excitatory amino acid receptors; Excitotoxicity; Nerve agent; Neuropathology; NMDA receptors; Organophosphorus compounds; Sarin; Seizures; Soman; Tabun; VX

Indexed keywords

AMINO ACID RECEPTOR BLOCKING AGENT; ANTICONVULSIVE AGENT; EXCITATORY AMINO ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; ORGANOPHOSPHORUS COMPOUND; SARIN; SOMAN; TABUN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICHOLINERGIC EFFECT; ARTICLE; COMA; CONTROLLED STUDY; DRUG INDUCED DISEASE; DRUG MECHANISM; EPILEPSY; FASCICULATION; NEUROPATHOLOGY; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; SEIZURE; SURVIVAL RATE; TREMOR;

ANIMALS; CHEMICAL WARFARE AGENTS; CHOLINESTERASE INHIBITORS; HUMANS; NERVOUS SYSTEM DISEASES; SEIZURES;

EID: 0030726679     PISSN: 01497634     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0149-7634(96)00050-4     Document Type: Article

References (200)

1. Anderson D.R., Gennings C., Carter W.H., Harris L.W., Lennox W.J., Bowersox S.L., Solana R.P. Efficacy comparison of scopolamine and diazepam against soman-induced debilitation in guinea pigs. Fundam. Appl. Toxicol. 22:1994;588-593.
2. Anderson D.R., Harris L.W., Bowersox S.L., Lennox W.J., Anders J.C. Efficacy of injectable anticholinergic drugs against soman-induced convulsive/subconvulsive activity. Drug Chem. Toxicol. 17:1994;139-148.
3. Ashani Y., Catravas G.N. Seizure-induced changes in the permeability of the blood-brain barrier following administration of anticholinesterase drugs to rat. Biochem. Pharmacol. 30:1981;2593-2601.
4. Auer R.N., Siesjo B.K. Biological differences between ischemia, hypoglycemia, and epilepsy. Ann. Neurol. 24:1988;699-707.
5. Baran H., Lassmann H., Sperk G., Seitelberger F., Hornykiewicz O. Effect of mannitol treatment on brain neurotransmitter markers in kainic acid-induced epilepsy. Neurosci. 21:1987;679-684.
6. Baskin, S.I.; Whitmer, M.P. The cardiac toxicology of organophosphorus agents. In: Baskin, S.I., ed. Principles of cardiac toxicology. Boca Raton, FL: CRC Press; 1991: 275-293.
7. Baze W.B. Soman-induced morphological changes: an overview in the non-human primate. J. Appl. Toxicol. 13:1993;173-177.
8. Ben-Ari Y. Limbic seizure and brain damage produced by kainic acid: mechanisms and relevance to human temporal lobe epilepsy. Neurosci. 14:1985;375-403.
9. Berridge, M.J. Inositol phosphates as second messengers. In: Putney, J.W., ed. Phosphoinositides in receptor mechanisms. New York: R. R. Liss; 1986: 25-45.
10. Berry W., Davis D.R. The use of carbamates and atropine in protection of animals against poisoning by 1,2,2-trimethylpropyl methylphosphonofluoridate. Biochem. Pharmacol. 19:1970;927-934.
11. Blanchet, G.; Carpentier, P.; Lallement, G.; Tarricone, A.; Sentenac, H.; Kamenka, J.-M. Anticonvulsant effect of N-[1-(2-thienyl) cyclohexyl]-piperidine (TCP) in soman poisoning. In: Kamenka, J.-M.; Domino, E.F., eds., Multiple sigma and PCP receptor ligands: mechanisms for neuromodulation and protection. Ann Arbor, MI: NPP Books; 1992; 831-840.
12. Blick D.W., Kerenyi S.Z., Miller S.A., Murphy M.R., Brown G.C., Hartgraves S.L. Behavioral toxicity of anticholinesterases in primates: chronic pyridostigmine and soman interactions. Pharmacol. Biochem. Behav. 38:1991;527-532.
13. Bodjarian N., Lallement G., Carpentier P., Baubichon D., Blanchet G. Soman-induced phosphoinositide hydrolysis in rat hippocampal slices: biochemical characterization. NeuroToxicol. 13:1992;715-722.
14. Bodjarian N., Carpentier P., Blanchet G., Baubichon D., Lallement G. Cholinergic activation of phosphoinositide metabolism during soman-induced seizures. NeuroRept. 4:1993;1191-1193.
15. Bokonjie D., Rosic N. Anticonvulsive and protective effects of diazepam and midazolam in rats poisoned by highly toxic organophosphorus compounds. Arh. hig. rada. toksikol. 42:1991;359-363.
16. Boskovic B. The treatment of soman poisoning and its perspectives. Fundam. Appl. Toxicol. 1:1981;203-213.
17. Braitman D.J., Sparenborg S. MK-801 protects against seizures induced by the cholinesterase inhibitor soman. Brain Res. Bull. 23:1989;145-148.
18. Brezenoff H.E., McGee J., Knight V. The hypertensive response to soman and its relation to brain cholinesterase inhibition. Acta Pharmacol. Toxicol. 55:1984;270-277.
19. Brown A.W., Brierly J.B. Anoxic-ischemic cell change in rat brain. Light microscopic and fine-structural observations. J. Neurol. Sci. 16:1972;59-84.
20. Brown A.W., Brierly J.B. The earliest alterations in rat neurons and astrocytes after anoxia-ischemia. Acta Neuropathol. 23:1973;9-22.
21. Brown A.W. Structural abnormalities in neurons. J. Clin. Pathol. 30. Suppl. (Royal College of Pathologists). 11:1977;155-169.
22. Burchfield J.L., Duffy F.H., Sim V.M. Persistent effects of sarin and dieldrin upon the primate electroencephalogram. Toxicol. Appl. Pharmacol. 35:1976;365-379.
23. Capacio B.R., Shih T.-M. Anticonvulsant actions of anticholinergic drugs in soman poisoning. Epilepsia. 32:1991;604-615.
24. Carpentier P., Delamanche I.S., Le Bert M., Blanchet G., Bouchaud C. Seizure-related opening of the blood-brain barrier induced by soman: possible correlation with the acute neuropathology observed in poisoned rats. NeuroToxicol. 11:1990;493-508.
25. Carpentier P., Lambrinidis M., Blanchet G. Early dendritic changes in hippocampal pyramidal neurons (field CA1) of rats subjected to acute soman intoxication: a light microscopic study. Brain Res. 541:1991;293-299.
26. Carpentier P., Foquin-Tarricone A., Bodjarian N., Rondouin G., Lerner-Natoli M., Kamenka J.-M., Blanchet G., Denoyer M., Lallement G. Anticonvulsant and antilethal effects of the phencyclidine derivative TCP in soman poisoning. NeuroToxicol. 15:1994;837-852.
27. Castro C.A., Gresham V.C., Finger A.V., Maxwell D.M., Solana R.P., Lenz D.E., Broomfield C.A. Behavioral decrements persist in rhesus monkeys trained on a serial probe recognition task despite protection against soman lethality by butyrylcholinesterase. Neurotoxicol. Teratol. 16:1994;145-148.
28. Castro C.A., Larsen T., Finger A.V., Solana R.P., McMaster S.B. Behavioral efficacy of diazepam against nerve agent exposure in rhesus monkey. Pharmacol. Biochem. Behav. 41:1991;159-164.
29. Celesia G.G., Booker H.E., Sato S. Brain and serum concentrations of diazepam in experimental epilepsy. Epilepsia. 15:1974;417-425.
30. Chollat-Namy A., Delamanche I.S., Bouchaud C. Variation in the expression of c-fos after intoxication by soman. Comparative study using in situ hybridization and immunohistochemistry. Brain Res. 603:1993;32-37.
31. Choi D.W. Calcium-mediated neurotoxicity: relationship to specific channel types and role in ischemic damage. Trends Neurosci. 11:1988;465-469.
32. Churchill L., Pazdernik T.L., Cross R.S., Giesler M.P., Nelson S.R., Samson F.E. Cholinergic systems influence local cerebral glucose use in specific anatomical areas. Neurosci. 20:1987;329-339.
33. Churchill L., Pazdernik T.L., Cross R.S., Nelson S.R., Samson F.E. Soman- or kainic acid-induced convulsions decrease muscarinic receptors but not benzodiazepine receptors. NeuroToxicol. 11:1990;57-72.
34. Churchill L., Pazdernik T.L., Jackson J.L., Nelson S.R., Samson F.E., McDonough J.H., McLeod C.G. Soman-induced brain lesions demonstrated by muscarinic receptor autoradiography. NeuroToxicol. 6:1985;81-90.
35. Clement J.G., Broxup B. Efficacy of diazepam and avizafone against soman-induced neuropathology in brain of rats. NeuroToxicol. 14:1993;485-504.
36. Clement J.G., Lee M.J. Soman-induced convulsions: significance of changes in levels of blood electrolytes, gases, glucose and insulin. Toxicol. Appl. Pharmacol. 55:1980;203-204.
37. Coleman I.W., Little P.E., Bannard R.A.B. Cholinolytics in the treatment of anticholinesterase poisoning. I. The effectiveness of certain cholinolytics in combination with an oxime for treatment of sarin poisoning Can. J. Biochem. Physiol. 40:1962;815-826.
38. Coleman I.W., Patton G.E., Bannard R.A.B. Cholinolytics in the treatment of anticholinesterase poisoning. V. The effectiveness of parpanit with oximes in the treatment of organophosphorus poisoning Can. J. Physiol. Pharmacol. 46:1968;109-117.
39. Coudray-Lucas C., Prioux-Guyonneau M., Sentenac H., Cohen Y., Wepierre J. Brain catecholamine metabolism changes and hypothermia in intoxication by anticholinesterase agents. Acta Pharmacol. Toxicol. 52:1983;224-229.
40. Coudray-Lucas C., Prioux-Guyonneau M., Sentenac H., Cohen Y., Wepierre J. Effects of physostigmine, paraoxon and soman on brain GABA level and metabolism. Acta Pharmacol. Toxicol. 55:1984;153-157.
41. Cummings, J.F. Neurophatological effects of the organophosphorus poison - soman. Final Report of Contract No. DAMD17-85-C-5022; Defense Technical Information Center No. AD-A216-520; 1989.
42. Deshpande S.S., Smith C.D., Filbert M.G. Assessment of primary neuronal culture as a model for soman-induced neurotoxicity and effectiveness of memantine as a neuroprotective drug. Arch. Toxicol. 14:1995;384-390.
43. Dirnhuber P., French M.C., Green D.M., Leadbeater L., Stratton J.A. The protection of primates against soman poisoning by pretreatment with pyridostigmine. J. Pharm. Pharmacol. 31:1979;295-299.
44. Duffy F.H., Burchfiel J.L. Long term effects of the organophosphate sarin on EEGs in monkeys and humans. NeuroToxicol. 1:1980;667-689.
45. Duffy F.H., Burchfiel J.L., Bartels P.H., Gaon M., Sim V.M. Long-term effects of an organophosphate upon the human electroencephalogram. Toxicol. Appl. Pharmacol. 47:1979;161-176.
46. Dunn M.A., Sidell F.R. Progress in medical defense against nerve agents. J. Am. Med. Ass. 262:1989;649-652.
47. A receptor complex in brain following limbic seizures produced by kainic acid. Neurosci. Abs. 14:1988;1036.
48. El-Etri M.M., Nickell W.T., Ennis M., Skau K.A., Shipley M. Brain norepinephrine reductions in soman-intoxicated rats: association with convulsions and AChE inhibition, time course, and relation to other monoamines. Exp. Neurol. 118:1992;153-163.
49. Ennis M., Shipley M.T. Tonic activation of locus coeruleus neurons by systemic or intracoerulear microinjection of an irreversible acetylcholinesterase inhibitor: increased discharge rate and induction of c-fos. Exp. Neurol. 118:1992;164-177.
50. Evans M.T., Griffiths T., Meldrum B. Early changes in the rat hippocampus following seizures induced by bicuculline or L-allyglycine: a light and electron microscope study. Neuropathol. Appl. Neurobiol. 9:1983;39-52.
51. Filbert M.G., Dochterman L.W., Smith C.D., Forster J.S., Phann S., Cann F.J. Effect of mannitol treatment on soman-induced brain and heart lesions in the rat. Drug Devel. Res. 30:1993;45-53.
52. Flynn C.J., Wecker L. Elevated choline levels in brain: a noncholinergic component of organophosphate toxicity. Biochem. Pharmacol. 35:1986;3115-3121.
53. Flynn C.J., Wecker L. Concomitant increases in the levels of choline and free fatty acids in rat brain: Evidence supporting the seizure-induced hydrolysis of phosphatidylcholine. J. Neurochem. 48:1987;1178-1184.
54. Fosbraey P., Wetherell J.R., French M.C. Neurotransmitter changes in guinea-pig brain regions following soman intoxication. J. Neurochem. 54:1990;72-79.
55. Fosbraey P., Wetherell J.R., French M.C. Effect of acute physostigmine-hyoscine pretreatment on the neurochemical changes produced by soman in the guinea pig. Neurochem. Int. 18:1991;265-273.
56. Gall D. The use of therapeutic mixtures in the treatment of cholinesterase inhibition. Fundam. Appl. Toxicol. 1:1981;214-216.
57. Gastaut, H.; Zifkin, B.G. Classification of the epilepsis. In: Faingold, C.L.; Fromm, G.H., eds. Drugs for control of epilepsy: actions on neuronal networks involved in seizure disorders. Boca Raton, FL: CRC Press; 1992: 349-360.
58. Glenn, J.F.; Hinman, D.J.; McMaster, S.B. Electroencephalographic correlates of nerve agent poisoning. In: Dun, N.J.; Perlman, R.L., ed. Neurobiology of acetylcholine. New York: Plenum Press; 1987: 503-534.
59. Goldman H., Berman R.F., Hazlett J., Murphy S. Cerebrovascular responses to soman: time and dose dependent effects. NeuroToxicol. 14:1993;469-484.
60. Gordon J.J., Leadbeater L., Maidment M.P. The protection of animals against organophosphate poisoning by pretreatment with a carbamate. Toxicol. Appl. Pharmacol. 43:1978;207-216.
61. Grange-Messent V., Bouchaud C. Effects of soman on cerebral astrocyte plasma membranes: a freeze-fracture study. Neurosci. Let. 178:1990;77-80.
62. Green D.M., Muir A.W., Stratton J.A., Inch T.D. Dual mechanisms of antidotal action of atropine-like drugs in poisoning by organophosphorus anticholinesterases. J. Pharm. Pharmacol. 29:1977;62-64.
63. Gross R.A. A brief history of epilepsy and its therapy in the western hemisphere. Epilepsy Res. 12:1992;65-74.
64. Haggerty G.C., Kurtz P.J., Armstrong R.D. Duration and intensity of behavioral change after sublethal exposure to soman in rats. Neurobehav. Toxicol. Teratol. 8:1986;695-702.
65. Hallcher L.M., Sherman W.R. The effects of lithium ion and other agents on the activity of myo-inositol-1-phosphatase from bovine brain. J. Biol. Chem. 255:1980;10896-10901.
66. Handforth A., Ackermann R.F. Hierarchy of seizure states in the electrogenic limbic status epilepticus model: behavioral and electrographic observations of initial states and temporal progression. Epilepsia. 33:1992;589-600.
67. Handforth A., Ackermann R.F. Electrogenic status epilepticus induced from numerous limbic sites. Epilepsy Res. 15:1993;21-26.
68. 14C-2-deoxyglucose method. Brain Res. Rev. 20:1995;1-23.
69. Hartgraves, S.L.; Murphy, M.R. Behavioral effects of low-dose nerve agents. In: Somani, S.M. ed. Chemical warfare agent. New York: Academic Press; 1992: 125-154.
70. Harris L.W., Gennings C., Carter W.H., Anderson D.R., Lennox W.J., Bowersox S.L., Solana R.P. Efficacy comparison of scopolamine (SCP) and diazepam (DZ) against soman-induced lethality in guinea pigs. Drug Chem. Toxicol. 17:1994;35-50.
71. Hayward I.J., Wall H.G., Jaax N.K., Wade J.V., Marlow D.D., Nold J.B. Decreased brain pathology in organophosphate-exposed rhesus monkeys following benzodiazepine therapy. J. Neurol. Sci. 98:1990;99-106.
72. Hirvonen M.-R., Paljarvi L., Naukkarinen A., Komulainen H., Savolainen K.M. Potentiation of malaoxon-induced convulsions by lithium: early neuronal injury, phosphoinositide signaling, and calcium. Toxicol. Appl. Pharmacol. 104:1990;276-289.
73. Ho I.K., Fernando J.C.R., Sivam S.P., Hoskin B. Roles of DA and GABA in neurotoxicity of organophosphorous cholinesterase inhibitors. Proc. West. Pharmacol. Soc. 27:1984;177-180.
74. Hymowitz N., Ploshnick A., Laemie L., Brezenoff H. Effects of repeated administration of soman on schedule-controlled behavior and brain in the rat. Neurotoxicol. Teratol. 12:1990;47-56.
75. Johnson D.D., Lowndes H.E. Reduction by diazepam of repetitive electrical activity and toxicity resulting from soman. Eur. J. Pharmacol. 28:1974;245-250.
76. Johnson D.D., Wilcox W.C. Studies on the mechanism of the protective and antidotal actions of diazepam in organophosphate poisoning. Eur. J. Pharmacol. 34:1975;127-132.
77. Jope R.S., Simonato M., Lally K. Acetylcholine content in rat brain is elevated by status epilepticus induced by lithium and pilocarpine. J. Neurochem. 49:1987;944-951.
78. Jovic R., Milosevic M. Effective doses of some cholinolytics in the treatment of anticholinesterase poisoning. Eur. J. Pharmacol. 12:1970;85-93.
79. Kadar T., Cohen G., Sahar R., Alkalay D., Shapira S. Long-term study of brain lesions following soman, in comparison to DFP and metrazol poisoning. Hum. Exp. Toxicol. 11:1992;517-523.
80. Kadar T., Shapira S., Cohen G., Sahar R., Alkalay D., Raveh L. Sarin-induced neuropathology in rats. Hum. Exp. Toxicol. 14:1995;252-259.
81. Kant G.J., Shih T.-M., Leu J.R., Raslear T.G., Mougey E.H. Long-term sequelae of soman exposure: hormonal rhythms two weeks postexposure to a single dose. Fundam. Appl. Toxicol. 10:1988;154-163.
82. Kar P.P., Matin M.A. Possible role of gamma-aminobutyric acid in paraoxon induced convulsions. J. Pharm. Pharmacol. 24:1972;996-997.
83. Keeler J.R., Hurst C.G., Dunn M.A. Pyridostigmine used as a nerve agent pretreatment under wartime conditions. J. Am. Med. Ass. 266:1991;693-695.
84. Kluwe, W.M.; Chinn, J.W.; Feder, J.W.; Olson, C.; Joiner, R. Efficacy of pyridostigmine pretreatment against acute soman intoxication in a primate model. Proceedings of the Sixth Medical Chemical Defense Bioscience Review, Aberdeen Proving Ground, MD, AD No. B121516; 1987: 227-234.
85. Koplovitz I., Romano J.A., Stewart J.R. Assessment of motor performance decrement following soman poisoning in mice. Drug Chem. Toxicol. 12:1989;221-235.
86. Lallement G., Carpentier P., Collet A., Baubichon D., Pernot-Marino I., Blanchet G. Extracellular acetycholine changes in rat limbic structures during soman-induced seizures. NeuroToxicol. 13:1992;557-568.
87. Lallement G., Carpentier P., Collet A., Pernot-Marino I., Baubichon D., Blanchet G. Effects of soman-induced seizures on different extracellular amino acid levels and on glutamate uptake in rat hippocampus. Brain Res. 563:1991;234-240.
88. Lallement, G.; Carpentier, P.; Collet, A.; Pernot-Marino, I.; Baubichon, D.; Sentenac-Roumanou, H.; Blanchet, G. Involvement of glutamatergic system in amygdala during soman-induced seizures: comparison with the hippocampus. Compte Rendus, Academy Science, Paris 313, Serie III; 1991: 421-426.
89. Lallement G., Carpentier P., Pernot-Marino I., Baubichon D., Collet A., Blanchet G. Involvement of the different rat hippocampal glutamatergic receptors in development of seizures induced by soman: an autoradiographic study. NeuroToxicol. 12:1991;655-664.
90. Lallement G., Carpentier P., Pernot-Marino I., Baubichon D., Collet A., Blanchet G. Transient impairment of the GABA-ergic function during initiation of soman-induced seizures. Brain Res. 629:1993;239-244.
91. Lallement G., Delamanche I.S., Pernot-Marino I., Baubichon D., Denoyer M., Carpentier P., Blanchet G. Neuroprotective activity of glutamate receptor antagonists against soman-induced hippocampal damage: quantification with an w3 site ligand. Brain Res. 618:1993;227-237.
92. Lallement G., Denoyer M., Collet A., Pernot-Marino I., Baubichon D., Monmaur P., Blanchet G. Changes in hippocampal acetylcholine and glutamate extracellular levels during soman-induced seizures: influence of septal cholinoceptive cells. Neurosci. Let. 139:1992;104-107.
93. Lallement G., Pernot-Marino I., Baubichon D., Burckhart M.-F., Carpentier P., Blanchet G. Modulation of soman-induced neuropathology with an anticonvulsant regimen. NeuroRep. 5:1994;2265-2268.
94. Lallement G., Pernot-Marino I., Foquin-Tarricone A., Baubichon D., Piras A., Blanchet G., Carpentier P. Antiepileptic effects of NBQX against soman-induced seizures. NeuroRep. 5:1994;425-428.
95. Lallement G., Pernot-Marino I., Foquin-Tarricone A., Baubichon D., Piras A., Blanchet G., Carpentier P. Coadministration of atropine, NBQX and TCP against soman-induced seizures. NeuroRep. 5:1994;1113-1117.
96. Lassmann H., Petsche U., Kitz K., Baran H., Sperk G., Seitelberger F., Hornykiewicz O. The role of brain edema in epileptic brain damage induced by systemic kainic acid injection. Neurosci. 13:1984;691-704.
97. Leadbeater L., Inns R.H., Rylands J.M. Treatment of poisoning by soman. Fundam. Appl. Toxicol. 5:1985;S225-S231.
98. Lebeda F.J., Wierwille R.C., VanMeter W.G., Sikora-VanMeter K.C. Acute ultrastructural alterations induced by soman and hypoxia in rat hippocampal CA3 pyramidal neurons. NeuroToxicol. 9:1988;9-22.
99. Lemercier G., Carpentier P., Sentenac-Roumanou H., Moralis P. Histological and histochemical changes in the central nervous system of the rat poisoned by an irreversible anticholinesterase organophosphorus compound. Acta Neuropathol. (Berl.). 61:1983;123-129.
100. Lipp J.A. Cerebral electrical activity following soman administration. Arch. Internat. Pharmacodyn. Ther. 175:1968;161-169.
101. Lipp J.A. Effect of diazepam upon soman-induced seizure activity and convulsions. EEG Clin. Neurophys. 32:1972;557-560.
102. Lipp J.A. Effect of benzodiazepine derivatives on soman-induced seizure activity and convulsions in the monkey. Arch. Internat. Pharmacodyn. Ther. 202:1973;244-251.
103. Liu D.D., Ueno E., Ho I.K., Hoskins B. Evidence that alterations in gamma-aminobutyric acid and acetylcholine in rat striata and cerebella are not related to soman-induced convulsions. J. Neurochem. 51:1988;181-187.
104. Liu D.D., Watanabe H.K., Ho I.K., Hoskins B. Acute effects of soman, sarin, and tabun on cyclic nucleotide metabolism in rat striatum. J. Toxicol. Environ. Health. 19:1986;23-32.
105. Lowenstein, D.H.; Simon, R.P. Antiepileptic drugs useful in status epilepticus. In: Faingold, C.L.; Fromm. G.H. eds. Drugs for control of epilepsy: actions on neuronal networks involved in seizure disorders. Boca Raton, FL: CRC Press; 1992: 513-525.
106. Lundy P.M., Magor G.F. Cyclic GMP concentrations in cerebellum following organophosphate administration. J. Pharm. Pharmac. 30:1978;251-252.
107. Lundy P.M., Magor G., Shaw R.K. Gamma aminobutyric acid metabolism in different areas of rat brain at the onset of soman-induced convulsions. Arch. Internat. Pharmacodyn. Ther. 234:1978;64-73.
108. Lundy P.M., Shaw R.K. Modification of cholinergically induced convulsive activity and cyclic GMP levels in the CNS. Neuropharmacol. 22:1983;55-63.
109. Lundy P.M., Shih T.-M. Examination of the role of central cholinergic mechanisms in the therapeutic effects of HI-6 in organophosphate poisoning. J. Neurochem. 40:1983;1321-1328.
110. Lynch M.R., Rice M.A., Robinson S.E. Dissociation of locomotor depression and ChE activity after DFP, soman and sarin. Pharmacol. Biochem. Behav. 24:1986;941-947.
111. Lynch T.J., Stratton C.S., Glenn J.F. Changes in brain pO2 during soman-induced seizures in the rat. Neurosci. Abs. 11:1985;1262.
112. Martin L.J., Doebler J.A., Shih T.-M., Anthony A. Protective effect of diazepam pretreatment on soman-induced brain lesion formation. Brain Res. 325:1985;287-289.
113. Maxwell D.M., Lenz D.E., Groff W.A., Kaminskis A., Froehlich H.L. The effects of blood flow and detoxification on in vivo cholinesterase inhibition by soman in rats. Toxicol. Appl. Pharmacol. 88:1987;66-76.
114. Mayer M.L., Westbrook G.L. Cellular mechanisms underlying excitotoxicity. Trend. Neurosci. 10:1987;59-61.
115. McDonough J.H., Dochterman L.W., Smith C.D., Shih T.-M. Protection against nerve agent-induced neuropathology, but not cardiac pathology, is associated with the anticonvulsant action of drug treatment. Neurotoxicol. 15:1995;123-132.
116. McDonough J.H., Hackley B.E., Cross R., Samson F., Nelson S. Brain regional glucose use during soman-induced seizures. NeuroToxicol. 4:1983;203-210.
117. McDonough J.H., Jaax N.K., Crowley R.A., Mays M.Z., Modrow H.E. Atropine and/or diazepam therapy protects against soman-induced neural and cardiac pathology. Fundam. Appl. Toxicol. 13:1989;256-276.
118. McDonough J.H., McLeod C.G., Nipwoda M.T. Direct micro-injection of soman or VX into the amygdala produces repetitive limbic convulsions and neuropathology. Brain Res. 435:1987;123-137.
119. McDonough J.H., Shih T.-M. Pharmacological modulation of soman-induced seizures. Neurosci. Biobehav. Rev. 17:1993;203-215.
120. McDonough J.H., Shih T.-M. A study of the N-methyl-D-aspartate antagonistic properties of anticholinergic drugs. Pharmacol. Biochem. Behav. 51:1995;249-253.
121. McDonough J.H., Shih T.-M., Adams N. Forebrain areas sensitive to the convulsant effects of the anticholinesterase agent VX. Neurosci. Abs. 19:1993;1630.
122. McDonough J.H., Smith R.F., Smith C.D. Behavioral correlates of soman-induced neuropathology: deficits in DRL acquisition. Neurobehav. Toxicol. Teratol. 8:1986;179-187.
123. McIntyre D.C., Nathanson D., Edson N. A new model of partial status epilepticus based on kindling. Brain Res. 250:1982;53-63.
124. McLeod C.G. Pathology of nerve agents: perspectives on medical management. Fundam. Appl. Toxicol. 5:1985;S10-S16.
125. McLeod C.G., Singer A.W., Harrington D.G. Acute neuropathology in soman poisoned rats. NeuroToxicol. 5:1984;53-58.
126. McLeod, C.G.; Wall, H.G. Pathology of experimental nerve agent poisoning. In: Dun, N.J.; Perlman, R.L. eds., Neurobiology of acetylcholine. New York: Plenum Press; 1987: 427-435.
127. Meldrum, B.S. Cell damage in epilepsy and the role of calcium in cytotoxicity. In: Delgado-Escueta, A.A.; Ward, A.A.; Woodbury, D.M.; Porter, R.J. eds., Basic mechanisms of the epilepsies. New York: Raven Press; 1986: 849-855.
128. Miller A.L., Medina M.A. Cerebral metabolic effects of organophosphorus anticholinesterase compounds. Metabol. Brain Dis. 1:1986;147-156.
129. Millis R.M., Archer P.W., Wittaker J.A., Trouth C.O. The role of hypoxia in organophosphrous nerve agent intoxication. NeuroToxicol. 9:1988;273-286.
130. Misulis K.E., Clinton M.E., Dettbarn W.-D., Gupta R.C. Differences in central and peripheral neural actions between soman and diisopropylfluorophosphate, organophosphorus inhibitors of acetylcholinesterase. Toxicol. Appl. Pharmacol. 89:1987;391-398.
131. Mobley P.L. The cholinesterase inhibitor soman increases inositol triphosphate in rat brain. Neuropharmacol. 29:1990;189-191.
132. Modrow H.E., Jaax N.K. Effect of soman exposure on the acquisition of an operant alternation task. Pharmacol. Biochem. Behav. 32:1989;49-53.
133. Monaghan D.T., Bridges R.J., Cotman C.W. The excitatory amino acid receptors: their classes, pharmacology, and distinct properties in the function of the central nervous system. Ann. Rev. Pharmacol. Toxicol. 29:1989;365-402.
134. Murphy M.R., Blick D.W., Dunn M.A., Fanton J.W., Hartgraves S.L. Diazepam as a treatment for nerve agent poisoning in primates. Aviat. Space Environ. Med. 64:1993;110-115.
135. Nelson S.R., Olson J.P. Role of early edema in the development of regional seizure-related brain damage. Neurochem. Res. 12:1987;561-564.
136. Olney, J.W. Excitotoxins: an overview. In: Fuxe, K.; Roberts, P.; Schwarcz, R. eds., Excitotoxins. London: Macmillan; 1983: 82-96.
137. Olney J.W., Price M.T., Labruyere J., Salles K.S., Frierdrich G., Mueller M., Silverman E. Anti-parkinsonian agents are phencyclidine agonists and N-methyl-aspartate antagonists. Eur. J. Pharmacol. 142:1987;319-320.
138. Olney J.W., Collins R.C., Sloviter R.S. Excitotoxic mechanisms of epileptic brain damage. Advan. Neurol. 44:1986;857-878.
139. Olney J.W., de Gubareff T., Labruyere J. Seizure-related brain damage produced by cholinergic agents. Nature. 301:1983;520-522.
140. Paxinos, G.; Butcher, L.L. Organizational principles of the brain as revealed by choline acetyltransferase and acetylcholinesterase distribution and projections. In: Paxinos, G. ed., The Rat Nervous System. Vol. 1.; Sydney: Academic Press; 1985: 487-522.
141. Pazdernik T.L., Cross R., Giesler M., Nelson S., Samson F., McDonough J.H. Delayed effects of soman: brain glucose use and pathology. NeuroToxicol. 6:1985;61-70.
142. Pazdernik T.L., Cross R., Giesler M., Samson F., Nelson S.R. Changes in local cerebral glucose utilization induced by convulsants. Neurosci. 14:1985;823-835.
143. Pazdernik T.L., Cross R., Nelson S.R., Samson F., McDonough J.H. Soman-induced depression of brain activity in TAB-pretreated rats: a 2-deoxyglucose study. NeuroToxicol. 4:1983;27-34.
144. Petrali J.P., Maxwell D.M., Lenz D.E., Mills K.R. Effect of an anticholinesterase compound on the ultrastructure and function of the rat blood-brain barrier: a review and experiment. J. Submicro. Cytol. Pathol. 23:1991;331-338.
145. Petras J.M. Soman neurotoxicity. Fundam. Appl. Toxicol. 1:1981;242.
146. Petras J.M. Neurology and neuropathology of soman-induced brain injury: an overview. J. Exp. Anal. Behav. 61:1994;319-329.
147. 35S]TBPS binding in entorhinal cortex-kindled rat brains. Brain Res. 570:1991;167-172.
148. Philippens I.H.C.H.M., Melchers B.P.C., DeGroot D.M.G., Wolthius O.L. Behavioral performance, brain histology, and EEG sequela after immediate combined atropine/diazepam treatment of soman-intoxicated rats. Pharmacol. Biochem. Behav. 42:1992;711-719.
149. Price M.T., Stewart G.R., Olney J.W. Procyclidine protects against soman neurotoxicity, even when administered after onset of convulsions. Neurosci. Abs. 15:1989;1349.
150. Prioux-Guyonneau M., Coudray-Lucas C., Coq H.M., Cohen Y., Wepierre J. Modification of rat brain 5-hydroxytryptamine metabolism by sublethal doses of organophosphate agents. Acta Pharmacol. Toxicol. 51:1982;278-284.
151. Raffaele K., Hughey D., Wenk G., Olton D., Modrow H., McDonough J.H. Long-term behavioral changes in rats following organophosphonate exposure. Pharmacol. Biochem. Behav. 27:1987;407-412.
152. Romano J.A., King J.M., Penetar D.M. A comparison of physostigmine and soman using taste aversion and nociception. Neurobehav. Toxicol. Teratol. 7:1985;243-249.
153. Romano J.A., Landauer M.R. Effects of the organophosphorus compound, O-ethyl-N-dimethyl-phosphoramidocyanidate (tabun) on flavor aversions, locomotor activity, and rotarod performance in rats. Fundam. Appl. Toxicol. 6:1986;62-68.
154. Rump S., Grudzinska E. Investigations on the effects of diazepam in acute experimental intoxication with fluostigmine. Arch. Toxicol. 32:1974;223-232.
155. Rump S., Grudzinska E., Edelwein Z. Effects of diazepam on abnormalities of bioelectrical activity of the rabbit's brain due to fluostigmine. Acta Nervousa Superior (Prague). 14:1972;176-177.
156. Rump S., Grudzinska E., Edelwein Z. Effects of diazepam on epileptiform patterns of bioelectrical activity of the rabbit's brain induced by fluostigmine. Neuropharmacol. 12:1973;813-817.
157. Samson F.E., Pazdernik T.L., Cross R.S., Churchill L., Giesler M.P., Nelson S.R. Brain regional activity and damage associated with organophosphate induced seizures: effects of atropine and benactyzine. Proc. West. Pharmacol. Soc. 28:1985;183-185.
158. Samson F.E., Pazdernik T.L., Cross R.S., Giesler M.P., Mewes K., Neson S.R., McDonough J.H. Soman induced changes in brain regional glucose use. Fundam. Appl. Pharmacol. 4:1985;S173-S183.
159. Savolainen K.M., Nelson S.R., Samson F.E., Pazdernik T.L. Soman-induced convulsions affect the inositol lipid signaling system: potentiation by lithium, attenuation by atropine and diazepam. Toxicol. Appl. Pharmacol. 96:1988;305-314.
160. Savolainen K.M., Terry J.B., Nelson S.R., Samson F.E., Pazdernik T.L. Convulsions and cerebral inositol-1-phosphate levels in rats treated with diisopropyl fluorophosphate. Pharmacol. Toxicol. 63:1988;137-138.
161. Scremin O., Shih T.-M., Corcoran K.D. Cerebral blood flow-metabolism coupling after administration of soman at non-toxic levels. Brain Res. Bull. 26:1991;353-356.
162. Shih T.-M. Time course effects of soman on acetylcholine and choline levels in six discrete areas of the rat brain. Psychopharmacol. (Berlin). 78:1982;170-175.
163. Shih T.-M. Anticonvulsant effects of diazepam and MK-801 in soman poisoning. Epilepsy Res. 7:1990;105-116.
164. Shih T.-M. Cholinergic actions of diazepam and atropine sulfate in soman poisoning. Brain Res. Bull. 26:1991;565-573.
165. Shih T.-M., Capacio B.R., Cook L.A. Effects of anticholinergic-antiparkinsonian drugs on striatal neurotransmitter levels of rats intoxicated with soman. Pharmacol. Biochem. Behav. 44:1993;615-622.
166. Shih T.-M., Harris S., Henry K., Koviak T., Jimmerson V.R. Relationship between soman-induced elevation of brain regional acetylcholine concentrations and lethality. Soc. Neurosci. Abs. 12:1986;891.
167. Shih T.-M., Koviak T.A., Capacio B.R. Anticonvulsants for poisoning by the organophosphorus compound soman: pharmacological mechanisms. Neurosci. Biobehav. Rev. 15:1991;349-362.
168. Shih T.-M., Lenz D.E., Maxwell D.M. Effects of repeated injection of sublethal doses of soman on behavior and on brain acetylcholine and choline concentrations in the rat. Psychopharmacol. 101:1990;489-496.
169. Shih T.-M., McDonough J.H. Neurochemical mechanisms and pharmacological control of soman-induced seizures and pathology. Can. J. Physiol. Pharmacol. 72((suppl.I)):1994;396.
170. Shih T.-M., Scremin O.U. Cerebral blood flow and metabolism in soman-induced convulsions. Brain Res. Bull. 28:1992;735-742.
171. Sidell F.R. Soman and sarin: clinical manifestations and treatment of accidental poisoning by organophosphates. Clin. Toxicol. 7:1974;1-17.
172. Sidell, F.R. Clinical considerations in nerve agent intoxication. In: Somani, S.M. ed. Chemical warfare agents. New York: Academic Press; 1992: 155-194.
173. Sidell F.R. Clinical effects of organophosphorus cholinesterase inhibitors. J. Appl. Toxicol. 14:1994;111-113.
174. Sikora-VanMeter K.C., VanMeter W.G., Wierwille R.C. Fine structure of cat CNS after soman exposure. Neurosci. Abs. 11:1985;155.
175. Sikora-VanMeter K.C., Wierwille R.C., Willetts J., VanMeter W.G. Morphological evidence for increased protein synthesis in CNS neurons after soman exposure. Fundam. Appl. Toxicol. 8:1987;23-38.
176. Singer A., Jaax N.K., Graham J. Acute neuropathology and cardiomyopathy in soman and sarin intoxicated rats. Toxicol. Let. 36:1987;243-249.
177. Sloviter R.S., Dempster D.W. "Epileptic" brain damage is replicated qualitatively in the rat hippocampus by central injection of glutamate or aspartate but not by GABA or acetylcholine. Brain Res. Bull. 15:1985;39-60.
178. Smith S.E., Durmuller N., Meldrum B.S. The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy. Eur. J. Pharmacol. 201:1991;179-183.
179. Sneddon W.B., Burnham W., Prowse S., Cheng J., Kish S.H. Reduced GABA-mediated chloride flux in entorhinal cortex-kindled rat brains. Epilepsy Res. 6:1990;18-22.
180. Soderfeldt B., Kalimo H., Olsson Y., Siesjo B. Pathogenesis of brain lesions caused by experimental epilepsy. Acta Neuropathol. 54:1981;219-231.
181. Sparenborg S., Brennecke L.H., Beers E.T. Pharmacological dissociation of the motor and electrical aspects of convulsive status epilepticus induced by the cholinesterase inhibitor soman. Epilepsy Res. 14:1993;95-103.
182. Sparenborg S., Brennecke L.H., Braitman D.J. Prevention of soman neurotoxicity by non-opioid antitussives. NeuroToxicol. 11:1990;509-520.
183. Sparenborg S., Brennecke L.H., Jaax N.K., Braitman D.J. Dizocilpine (MK-801) arrests status epilepticus and prevents brain damage induced by soman. Neuropharmacol. 31:1992;357-368.
184. 2-dibutyryl adenosine 3′,5′-monophosphate on synthesis and survival. Toxicol. Appl. Pharmacol. 41:1977;79-90.
185. Szilagyi M., Grey P.J., Dawson R.M. Effects of the nerve agents soman and tabun on the uptake and release of GABA and glutamate in synaptosomes of guinea pig cerebral cortex. Gen. Pharmacol. 24:1993;663-668.
186. Tassinari C.A., Daniele O., Michelucci R., Bureau M., Draver C., Roger J. Benzodiazepines: efficacy in status epilepticus. Adv. Neurol. 34:1983;465-475.
187. Taylor, P. Anticholinesterase agents. In: Gilman, A.G.; Goodman, L.S.; Rall, T.W.; Murad, F. eds., The pharmacological basis of therapeutics (6th ed.). New York: Macmillan; 1985: 110-129.
188. Thornton, K.R.; Brigden, E.G. Morphological changes in the brains of guinea pigs following VX poisoning. Suffield Technical Paper No. 230; 1962.
189. Thornton, K.R.; Fukuyama, G.S. Morphological changes in the brain of M. Mulatta treated for VX poisoning with atropine, metaraminol and P2S. Suffield Technical Paper No. 228; 1961.
190. Tietz E.I., Chiu T.H. Regional GABA-stimulated chloride uptake in amygdala-kindled rats. Neurosci. Let. 123:1991;269-272.
191. Tryphonas L., Clement J.G. Histomorphogenesis of soman-induced encephalocardiomyopathy in Sprague-Dawley rats. Toxicol. Pathol. 23:1995;393-409.
192. Tryphonas L., Veinot J.P., Clement J.G. Early histopathologic and ultrastructural changes in the heart of Sprague-Dawley rats following administration of soman. Toxicol. Pathol. 24:1996;190-198.
193. Turski L., Ikonomidou C., Turski W.A., Bortolotto Z.A., Cavalheiro E.A. Cholinergic mechanisms and epileptogenesis. The seizures induced by pilocarpine: a novel experimental model of intractable epilepsy. Synapse. 3:1989;154-171.
194. Veronesi B., Jones K., Pope C. The neurotoxicity of subchronic acetylcholinesterase (AChE) inhibition in rat hippocampus. Toxicol. Appl. Pharmacol. 104:1990;440-456.
195. von Bredow J., Corcoran K., Maitland G., Kaminskis A., Adams N., Wade J. Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication. Fundam. Appl. Toxicol. 17:1991;782-789.
196. von Bredow J.D., Adams N.L., Groff W.A., Vick J.A. Effectiveness of oral pyridostigmine pretreatment and cholinolyticoxime therapy against soman intoxication in nonhuman primates. Fundam. Appl. Toxicol. 17:1991;761-770.
197. Vale J.A., Scott G.W. Organophosphorus poisoning. Guy's Hosp. Rep. 123:1974;13-25.
198. Wade J.V., Samson F.E., Nelson S.R., Pazdernik T.L. Changes in extracellular amino acids during soman- and kainic acid-induced seizure. J. Neurochem. 49:1987;645-650.
199. Wescoe W.C., Green R.E., McNamara B.P., Krop S. The influence of atropine and scopolamine in the central effects of DFP. J. Pharmacol. Exp. Ther. 92:1948;63-72.
200. Wills, J.H. Pharmacological antagonists of the anticholinesterase agents. In: Koelle, G.B. ed. Cholinesterases and Anticholinesterase Agents. Handbuch der Experimentellen Pharmakologie. Berlin: Springer-Verlag; 1963: 883-920.